We are delighted to invite you to the Fourth Annual Primary Care MASLD/MASH Summit 2025, taking place virtually on December 4, 2025.

The Summit will bring together primary care professionals, hepatologists, researchers, and public health leaders to advance the understanding and management of MASLD/MASH in clinical practice. All sessions will be delivered in English with simultaneous interpretation in French.

The program features eight in-depth sessions covering current research, practical diagnostic approaches, and real-world management strategies. Attendees will gain valuable insights into early detection, integrated care pathways, and the role of interdisciplinary collaboration. Highlights include:

  • Interactive case studies and expert-led panel discussions.
  • The Patient Perspective Session, offering a firsthand look at the lived experience of those affected by MASLD and MASH, emphasizing the importance of patient-centered care.
  • A concluding multidisciplinary panel with a primary care physician, nurse practitioner, hepatologist, discussing real-world application of strategies, best practices, and diagnostic challenges.

The summit is designed to empower healthcare professionals with the latest tools, resources, and clinical insights to improve outcomes for patients living with MASLD and MASH.

We invite you to register now and join us for this important event that will help shape the future of MASLD and MASH care in Canada and beyond.

On behalf of our co-chairs and esteemed faculty, we look forward to your participation and a dynamic exchange of ideas.

Michael Betel

President & Founder,
The Fatty Liver Alliance

Dr. Mark Swain, MD

Professor of Medicine,
University of Calgary

This year marks a special milestone:

We’re also launching the First European Annual Primary Care MASLD/MASH Summit, held on the same day, to foster international collaboration and highlight region-specific challenges and innovations. 

The Summit will bring together primary care professionals, hepatologists, researchers, and public health leaders to advance the understanding and management of MASLD/MASH in clinical practice.

On behalf of our co-chairs and esteemed faculty, we eagerly anticipate your virtual participation in this crucial meeting that will shape the future of MASLD and MASH practice across Europe and beyond.